Abstract | RATIONALE: PATIENT CONCERNS: DIAGNOSES: The patient was diagnosed as choriocarcinoma FIGO stage IV and the score of the Prognostic Scoring Index modified by the WHO was 15. INTERVENTIONS: OUTCOMES: The patient achieved remission after 9 cycles of chemotherapy. She has been followed up for 14 months with no signs of tumor recurrence. LESSONS: The diagnosis of choriocarcinoma may be difficult, especially in the setting with the limit of medical resources. The application of various diagnostic techniques such as x-ray, computed tomography, and magnetic resonance imaging is helpful for evaluating the patient's condition.
|
Authors | Zhen Ren, Li Yu, Mengnv Xie, Yiyi Liang, Fang Zhu, Rui Huang, Zhibang Zhang, Chun Fu |
Journal | Medicine
(Medicine (Baltimore))
Vol. 97
Issue 21
Pg. e10794
(May 2018)
ISSN: 1536-5964 [Electronic] United States |
PMID | 29794762
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Dactinomycin
- Vincristine
- Etoposide
- Cyclophosphamide
- Methotrexate
|
Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Blood Transfusion
(methods)
- Brain
(pathology)
- Brain Neoplasms
(drug therapy, secondary)
- Choriocarcinoma
(complications, pathology, therapy)
- Cyclophosphamide
(therapeutic use)
- Dactinomycin
(therapeutic use)
- Etoposide
(therapeutic use)
- Female
- Hemorrhage
(etiology, therapy)
- Hemostatic Techniques
- Humans
- Magnetic Resonance Imaging
- Methotrexate
(therapeutic use)
- Pregnancy
- Tomography, X-Ray Computed
- Uterine Neoplasms
(complications, pathology, therapy)
- Vincristine
(therapeutic use)
|